LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences, a leading provider of novel molecular diagnostic tests, has announced the appointment of Dr. Angelo M. De Marzo as Chief Medical Officer.
Angelo M. De Marzo, M.D., Ph.D., comes to Predictive Biosciences with an extensive background in prostate cancer research and urological pathology practice. Dr. De Marzo has been a faculty member at The Johns Hopkins University (JHU) School of Medicine since 1998, most recently as Professor of Pathology, Urology, and Oncology; Director of the Pathology Core for the Specialized Program of Research Excellence (SPORE) in prostate cancer.
